$-0.11 EPS Expected for Applied DNA Sciences Inc (APDN)

November 19, 2017 - By Winifred Garcia

 $ 0.11 EPS Expected for Applied DNA Sciences Inc (APDN)
Investors sentiment decreased to 0.73 in 2017 Q2. Its down 0.65, from 1.38 in 2017Q1. It fall, as 4 investors sold Applied DNA Sciences Inc shares while 7 reduced holdings. 4 funds opened positions while 4 raised stakes. 2.49 million shares or 25.31% less from 3.33 million shares in 2017Q1 were reported.
Morgan Stanley holds 0% of its portfolio in Applied DNA Sciences Inc (NASDAQ:APDN) for 112,834 shares. Sabby Lc, a New Jersey-based fund reported 987,593 shares. Geneva Advsrs Ltd Co invested in 0% or 35,196 shares. Chase Investment Counsel accumulated 77,563 shares. D Scott Neal holds 0% of its portfolio in Applied DNA Sciences Inc (NASDAQ:APDN) for 384 shares. California Employees Retirement Sys accumulated 36,200 shares. Natl Bank Of Mellon holds 17,200 shares. Benchmark Capital Advisors has invested 0.07% in Applied DNA Sciences Inc (NASDAQ:APDN). Commonwealth Equity Serv Inc accumulated 19,694 shares or 0% of the stock. Dumont Blake Ltd Company holds 18,412 shares. Wells Fargo Mn stated it has 0% of its portfolio in Applied DNA Sciences Inc (NASDAQ:APDN). New York-based Goldman Sachs Grp Inc Inc Inc has invested 0% in Applied DNA Sciences Inc (NASDAQ:APDN). The Kansas-based Creative Planning has invested 0% in Applied DNA Sciences Inc (NASDAQ:APDN). Fincl Bank Of Montreal Can invested in 0% or 12,200 shares. Taurus Asset Mgmt Ltd Limited Liability Company stated it has 0% in Applied DNA Sciences Inc (NASDAQ:APDN).

Analysts expect Applied DNA Sciences Inc (NASDAQ:APDN) to report $-0.11 EPS on December, 5.They anticipate $0.01 EPS change or 10.00 % from last quarter’s $-0.1 EPS. After having $-0.10 EPS previously, Applied DNA Sciences Inc’s analysts see 10.00 % EPS growth. The stock increased 5.88% or $0.13 on November 17, reaching $2.34. About 39,570 shares traded. Applied DNA Sciences Inc (NASDAQ:APDN) has declined 49.09% since November 19, 2016 and is downtrending. It has underperformed by 65.79% the S&P500.

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The company has market cap of $64.06 million. The Firm is also engaged in the large-scale production of specific deoxyribonucleic acid sequences using the polymerase chain reaction (PCR). It currently has negative earnings. The Company’s principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

Another recent and important Applied DNA Sciences Inc (NASDAQ:APDN) news was published by Marketwired.com which published an article titled: “Applied DNA Sciences Signs 5-Year Supply Agreement for Bulk DNA Manufacturing” on April 20, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: